Investments
bit.bio raises $30 Million led by M&G Investments
bit.bio raises $30 Million led by M&G Investments to focus on tools for the research, drug discovery and cell therapy markets. ...
Cambridge Index falls 0.7%
The Cambridge Index dropped 152.2 points or 0.7% to close at 21,517.6, as four out of the top ten index heavyweights posted weekly losses in their share price. ...
Yangtze River Delta Innovation challenge boosts new materials industry and showcases regional growth
On November 26, 2024, the Yangtze River Delta (Nanjing Metropolitan Area) Innovation Challenge Season's New Materials Industry event was successfully held in Jurong. Representatives from universities, research institutes, and enterprises from Shanghai, Nanjing, Zhenjiang, and other area...
Cambridge Index falls 2.6%
The Cambridge Index declined 576.07 points or 2.6% to close at 21,941.7, as eight out of the top ten index heavyweights posted weekly losses in their share price. ...
Anne Rosette - where is your next Holiday? Even your next investment?
The CEO of the Seychelles Investment Board (SIB) reveals the Country's SDG Investor Map on her visit to Cambridge. Anne Rosette was on a mission to recruit High Networth Individuals and institutional investors who are out for new investment opportunities in international markets. So, wi...
Babraham Research Campus’ £3.15bn life science ecosystem soars
New report reveals how groundbreaking research at the Campus is delivering major gains for UK economic growth and job creation. ...
Cambridge Index rises 2.5%
The Cambridge Index climbed 546.07 points or 2.5% to close at 22,517.8, as one out of the top ten index heavyweights posted weekly gains in its share price. ...
Tristan backs £300m+ life sciences platform
Tristan Capital Partners’ debt fund has refinanced a £310m prime life science portfolio located across Cambridge and Oxford, Green Street News can reveal. ...
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects Glasgow, UK, 20 November...
The EpiCentre is working with Microsoft to support innovative early-stage businesses
Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses. ...